Cosmos Health Inc. said it is evaluating strategic options to monetize its wholly owned real estate portfolio, citing an estimated combined fair market value of about $15 million for its Cana Laboratories manufacturing facility and CosmoFarm logistics center, based on independent valuation reports, market data, and comparable transactions. The company said this estimate covers land and buildings only and excludes machinery and equipment. Cosmos Health noted the estimated real estate value exceeds its market capitalization of about $13.5 million as of Feb. 17, 2026, and referenced reported stockholders’ equity (book value) of $23.1 million as of Q3 2025. Potential alternatives under review include an outright sale, joint ventures, and sale-leaseback transactions, with possible uses of proceeds including debt reduction and reinvestment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602191130PRIMZONEFULLFEED9657742) on February 19, 2026, and is solely responsible for the information contained therein.